KSL Biomedical Acquires Pulse Scientific

KSL Biomedical Inc., developer of novel diagnostic and therapeutic applications for immunology, oncology, virology, and genomics, has expanded into Canada with the acquisition of Pulse Scientific Inc. a diagnostic products manufacturer and distributor of medical, laboratory and research products located in Toronto.

With the incorporation of KSL Biomedical Canada Inc., and the acquisition of Pulse Scientific, KSL extends its international base for product distribution and laboratory sales, positioning the company to merge additional technology, business lines, and acquisition targets in Burlington, the greater Toronto Area (GTA), and beyond.

Pulse Scientific specializes in the manufacturing and distribution of technical microbiology products and controls for clinical, industrial, and pharmaceutical customers, as well as in-vitro diagnostic (IVD) tests for laboratories and physicians. The company is ISO 13485 certified and licensed by Health Canada, positioning it to distribute medical devices and in-vitro diagnostics in Canada, Europe, and many other markets throughout the world.

“Our leadership team brings to Canada decades of scientific training and experience in diagnostics and deep relationships with market leaders who can assist in identifying emerging industry opportunities and introducing novel applications to address them. We expect the acquisition to invigorate access to markets for existing Pulse Scientific and KSL Biomedical products, as well as complementary products to be identified by our incoming Canadian business development team,” said Kevin Lawson, president and CEO of KSL Biomedical.

Presenting a number of synergistic opportunities, the acquisition allows KSL to add proprietary products and services to its pipeline, including exclusive diagnostics, laboratory products, medical devices, and assays, utilizing proprietary biomarkers and instrumentation.

“It is an exciting opportunity for Pulse Scientific to be part of a vibrant and forward-thinking organization like KSL. The clear business vision and strategy planning, coupled with strong business ethics among the principals will bring continual success to their corporation. I personally will be able to contribute in sales and marketing efforts with rewarding experiences,” said Allen Chan, president of Pulse Scientific.

As a regulatory agent and contract research organization (CRO), KSL is well positioned to secure Health Canada clearance for manufacturers outside of Canada seeking access to the Canadian market and Canadian companies seeking regulatory clearances in large markets outside of Canada.

With the establishment of KSL Biomedical Canada, the company is now looking to build a strong, dynamic leadership team to run the new division. “We are always looking to grow KSL whether through innovation spearheaded by our various diagnostic teams or from outside the company; we are open to collaborative business opportunities,” added Lawson. “We’re also recruiting professionals who can accelerate our growth, including leaders for our Canada unit. Specifically, we expect to hire a number of positions in business development, sales, and R&D.”

Pulse Scientific is located on the shores of Lake Ontario between Toronto and Niagara Falls in Burlington, Ontario. 

KSL Biomedical Inc. is a translational medicine technology company that develops innovative diagnostic and therapeutic IP impacting immunology, oncology, virology, and genomics. Investing in basic research and licensing for novel technologies to improve patient outcomes, KSL specializes in early diagnosis and companion diagnostics to facilitate effective therapy. KSL offers proprietary diagnostic services through partnerships with investigators and institutions, and operates several national reference laboratories in North America—including KSL Diagnostics, which is both CAP and CLIA certified and the only laboratory in New York state to achieve ISO 15189 standards of excellence, Beutner Laboratories and Robert Guthrie Laboratory. With more than 25 years of industry experience, the KSL team also offers technology and regulatory consulting services to establish and protect bioscience IP through international regulatory clearance and licensing, while also supporting numerous concurrent clinical studies.